Kenneth B. Kirby
President & Chief Executive Officer

Mr. Kirby founded TTI in 1990 and has overseen both operations and technical
development for TTI. He is the co-inventor of the TDS® technology. In the late
1980s, he identified a novel transdermally active pharmaceutical compound,
negotiated a license for its patents, raised the seed capital and subsequent
mezzanine financing, formulated the product, designed the packaging, engaged
its manufacturing and began marketing the product in the United States. Mr. Kirby
received a B.A. in pre-medical studies from Florida State University with an
emphasis in clinical psychopharmacology. He is a member of Phi Beta Kappa
and the American Chemical Society. Kirby also is a Paul Harris Fellow of the
Rotary International Foundation and serves on the Board of Advisors of the
Jim Moran Institute for Global Entrepreneurship at Florida State University.

Bruce M. Crawford
Vice President

Mr. Crawford joined TTI in late 1994, bringing with him vast technology
development experience in submersible information gathering. Prior to his
current appointment at TTI, he served as President of Perry Offshore Inc., which
was successfully sold to Martin Marietta in 1994. Mr. Crawford received his B.S.
from Brown University and M.B.A. from the University of Rhode Island. Mr. Crawford
has had a successful career as a consultant to undersea exploration companies.

Chandan A.S. Alam, B. Sc., M.D.
Vice President, Development

Chandan A.S. Alam is currently the Vice President and Chief Scientific Officer. Dr. Alam is also a Director. His main area of interest is the transdermal delivery of drugs and he has completed five successful clinical trials of the TDS®.  From 2005 to 2007 Dr. Alam was Senior Scientist and head of the Experimental Pathology group at the William Harvey Research Institute. Dr. Alam is a Director with responsibility for Academic Collaborations – William Harvey Research Institute, a Director with responsibility for Business Development – William Harvey Research Limited, which is the commercial entity for technology transfer at the institute. Dr. Alam has published 52 papers on angiogenesis, various animal models of disease and transdermal delivery of drugs and has presented widely at international conferences.  Dr. Alam is co-inventor of two US Patents - No. 5,847,002 and 6,596,703 which have developed from his work.  Dr. Alam is a member of the East London and City Medical Ethics Committee. Dr. Alam began his research collaboration with TTI on July 1, 2001.  Dr. Alam received his Bachelor of Science (BSc) from London Guildhall University and his MD from St. Georges School of Medicine, Grenada.  Dr. Alam also has a Bachelors degree in Architecture from the University of London.